Open House pharmaceutical discount agreements for the active substance Etravirin, ATC J05AG04

Summary

The procurement concerns non-exclusive discount agreements for medicines with the active substance Etravirin (ATC J05AG04) under an Open House model. The objective is to establish non-exclusive discount contracts for medicines for the period from 01 November 2026 to 31 October 2028, with the possibility of contract conclusion at any time during the period. Bidders must comply with the qualification, suitability and compliance requirements described in the tender documents and submit the required evidence.